Comparing Dihydroergotamine Mesylate and Sumatriptan in the Management of Acute Migraine
- 1 July 1996
- journal article
- clinical trial
- Published by Springer Nature in PharmacoEconomics
- Vol. 10 (1) , 59-71
- https://doi.org/10.2165/00019053-199610010-00006
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A Double-blind Study of Subcutaneous Dihydroergotamine vs Subcutaneous Sumatriptan in the Treatment of Acute MigraineArchives of Neurology, 1996
- A literature review comparing the economic, clinical, and humanistic attributes of dihydroergotamine and sumatriptan.1994
- Recurrent migraine: cost-effective care.1994
- Epidemiology of MigraineNeuroepidemiology, 1993
- Migraine With Aura and Migraine Without Aura: An Epidemiological StudyCephalalgia, 1992
- Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors.1992
- Clinical Experience With Patient Administered Subcutaneous Dihydroergotamine Mesylate in Refractory HeadachesHeadache: The Journal of Head and Face Pain, 1992
- Specific Headache Phenomena: Their Frequency and CoincidenceHeadache: The Journal of Head and Face Pain, 1990
- Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover StudyCephalalgia, 1988
- Dihydroergotamine in the treatment of migraine; preliminary clinical observations.1945